Results 171 to 180 of about 278,336 (309)

Perioperative Rehabilitation and Initiation of Adjuvant Chemotherapy in Resected Non‐Small Cell Lung Cancer

International Journal of Cancer, EarlyView.
ABSTRACT Adjuvant chemotherapy can improve outcomes for patients who have undergone lung cancer resection, and perioperative rehabilitation may help maintain the physical condition necessary to receive adjuvant chemotherapy. This observational cohort study investigated the impact of perioperative rehabilitation on the administration of postoperative ...
Shinkichi Takamori, Tateaki Naito, Nobuko Konishi, Tetsuya Tsuji, Ikumi Takashima, Ryotaro Ide, Masakazu Fujiwara, Atsuki Yamamoto, Yusuke Takagi, Mizue Ogi, Shinya Uematsu, Hiroshi Kitagawa, Koichi Takayama   +12 more
wiley   +1 more source

Real-World Treatment Patterns and Clinical Outcomes After First-Line Therapy in Patients with KRAS G12C-Mutant Advanced Non-Small-Cell Lung Cancer in the United States. [PDF]

Cancers (Basel)
Sheffield KM, Puri T, Thoele K, Karu H, Mansharamani A, Uprety D.   +5 more
europepmc   +1 more source

LncRNAs and EGFRvIII sequestered in TEPs enable blood-based NSCLC diagnosis

, 2018
Chang-Liang Luo,1,* Zhi-Gao Xu,2,* Hao Chen,2 Jia Ji,1 Yu-Hui Wang,1 Wei Hu,1 Kun Wang,3 Wu-Wen Zhang,1 Chun-Hui Yuan,4 Fu-Bing Wang1 1Department of Laboratory Medicine, Zhongnan Hospital of Wuhan University, Wuhan, China; 2Department of Pathology ...
Zhang WW, Hu W, Luo CL, Yuan CH, Wang FB, Ji J, Chen H, Xu ZG, Wang YH, Wang K   +9 more
core  

Impact of Molecular Alterations on Survival in Biliary Tract Cancers: A Retrospective Belgian Cohort Study

International Journal of Cancer, EarlyView.
ABSTRACT Biliary tract cancers (BTCs) are aggressive malignancies associated with a poor prognosis. Although molecular profiling is recommended to guide therapeutic decision‐making, real‐practice data on the prevalence and prognostic significance of genomic alterations in European BTC cohorts remain limited.
Jorine Arnouts, Léon C. van Kempen, Senada Koljenović, Helena Oliveres, Pieterjan Vanclooster, Hans Prenen, Caro De Weerdt, Siddharth Chhajlani, Geert Roeyen, Laure Sorber, Koen De Winne, Jonas Dahnoun, Greetje Vanhoutte, Timon Vandamme, Karen Zwaenepoel   +14 more
wiley   +1 more source

Dauriporphine Suppresses Cell Proliferation, Metastasis, and Stemness of Non-Small Cell Lung Cancer Through the Regulation of the USP7/CASK. [PDF]

Drug Dev Res
Hou P, Wu Q.
europepmc   +1 more source

DIAGNOSIS AND THERAPY FOR PATIENTS WITH RARE HISTOLOGICAL SUBTYPES OF NON-SMALL CELL LUNG CANCER (NSCLC): A MONOCENTRIC OBSERVATIONAL RETROSPECTIVE STUDY

reservedPresupposti dello studio. Secondo i dati pubblicati dalla WHO nel 2021, solo il 5% dei casi di NSCLC avanzati sono riconducibili a istotipi tumorali rari, intesi come tutte quelle entità istologiche appartenenti ai NSCLC ad eccezione di ...
FOGLIA, LISA
core  

Clinical Translation of Patient‐Derived Organoids: Perspectives for Personalized Therapy in Cancer

International Journal of Cancer, EarlyView.
ABSTRACT Patient‐derived organoids (PDO) are accelerating precision medicine. These biological platforms allow for the autologous in vitro expansion of material from cancer patients in a considerably short period of time. These three‐dimensional models can faithfully recapitulate aspects of tissue heterogeneity, architecture, and relevant cellular ...
Haiyan Yue, Daniele Carchidi, Philipp Schmucker, Roland Seiler, Bernhard Kiss, Catarina Macedo‐Silva, Marianna Kruithof‐de Julio   +6 more
wiley   +1 more source

Integrated bioinformatics and feature selection-based discovery of ADP-ribosylation-associated biomarkers in non-small cell lung cancer. [PDF]

Oncol Lett
He J, Zhao Q, Zhao H, Zhang H, Hu Z, Kong L, Wang Z, Yan J, Yang S, Liu S.   +9 more
europepmc   +1 more source

IINS Vs CALLY Index: A Battle of Prognostic Value in NSCLC Patients Following Surgery [PDF]

Hao Cheng,1,* Jiao Ma,1,* Fengyu Zhao,2 Yiwei Liu,3 Jie Wu,4 Tao Wu,1 Hui Li,1 Boxiang Zhang,3 Hui Liu,5 Junke Fu,3 Haiqi He,3 Cailin Zhu,3 Hong Ren,3 Chengcheng Yang,2 Sida Qin3 1Department of Rehabilitation, The First Affiliated Hospital of Xi ...
Liu H, Wu J, Li H, He H, Yang C, Zhu C, Qin S, Ren H, Liu Y, Fu J, Zhao F, Ma J, Wu T, Cheng H, Zhang B   +14 more
core  

Cysteine Peptidases in Antitumor Immunity: Unraveling Antigen‐Presenting Cell Regulation and Therapeutic Potential

iMetaMed, EarlyView.
This review systematically summarizes the central role of cysteine peptidases in modulating antigen‐presenting cell (APC) function and antitumor immune responses, highlighting their critical significance in overcoming tumor immune evasion. Current research has established that cysteine peptidase subtypes, including cathepsins B, S, L, and X, exert ...
Yimao Wu, Xiaoyan Chen, Zichang Chen, Yalun Liang, Gokhan Zengin, Qian Zhang, Wenlong Sun, Meng‐Yao Li   +7 more
wiley   +1 more source